For instance, treatment with recombinant tPA reduces Aβ burden in AD mice [79], and partial (heterozygous) or complete deficiency (homozygous) of tPA significantly worsens Aβ deposition and overall disease pathology in AD mice [77]. The gene discussed is PLAT; the disease is Alzheimer disease.